StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries Manufacturing & R&D Facilities — Europe by Year

Teva Pharmaceutical Industries Manufacturing & R&D Facilities — Europe: 23 in FY2025, down 8.0% from a year earlier. That is the lowest of the 9 years on record here.

Latest, FY2025
23
Period ended Dec 31, 2025
Change on a year earlier
-8.0%
25 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| Europe | 23 | 8,878”

Source: Form 10-K (0001193125-26-034532) ↗

Reported in SEC Form 10-K (Item 2. Properties).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedManufacturing & R&D Facilities — EuropeYear on yearSource
FY2025Dec 31, 202523-8.0%Form 10-K (0001193125-26-034532) ↗
FY2024Dec 31, 2024250.0%Form 10-K (0001193125-25-020826) ↗
FY2023Dec 31, 202325-28.6%Form 10-K (0001193125-24-031005) ↗
FY2022Dec 31, 202235+16.7%Form 10-K (0001193125-23-031250) ↗
FY2021Dec 31, 202130-6.2%Form 10-K (0001193125-22-032667) ↗
FY2020Dec 31, 202032-5.9%Form 10-K (0001193125-21-036239) ↗
FY2019Dec 31, 201934+9.7%Form 10-K (0001193125-20-044221) ↗
FY2018Dec 31, 201831-6.1%Form 10-K (0001193125-19-043564) ↗
FY2017Dec 31, 201733–Form 10-K (0001193125-18-039076) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Manufacturing & R&D Facilities — Europe, annual FY2017–FY2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fac-eur-count

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?